Could a popular Weight-Loss drug increase surgery risks?
NCT ID NCT07398222
Summary
This study is checking if people taking the medication tirzepatide (for diabetes or weight loss) still have a full stomach even after fasting for 8 hours. Researchers will use a simple ultrasound scan on 30 volunteers to measure stomach contents. The goal is to understand if this medication increases the risk of stomach contents getting into the lungs during anesthesia.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FULL STOMACH STATUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Israelita Albert Einstein
RECRUITINGSão Paulo, São Paulo, 05652900, Brazil
Conditions
Explore the condition pages connected to this study.